ADAR1 Capital’s Daniel Schneeberger buys $1.6 million of Tenax Therapeutics shares

• ADAR1 Capital Management raised its Tenax Therapeutics stake, adding 900,000 common shares in open-market purchases.
• Holdings climbed to 6,524,151 shares, held indirectly through private investment funds managed by ADAR1.
• Weighted average purchase price was USD 1.78 per share.
• Filing also lists Daniel Schneeberger as a 10% owner.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000020), on September 08, 2026, and is solely responsible for the information contained therein.